tirzepatide and alcohol reduction reduces drinking relapse-like behaviours in rodents Can a weight loss drug

The popularity of these drugs has, however, contributed to significant shortages, making it difficult for patients to access them

08 Nov SAHPRAs position on GLP1 and GIP-GLP1 products that are compounded, substandard and falsified Pretoria, 08 November 2024 The South African Health Products Regulatory Authority (SAHPRA) is concerned about the proliferation of falsified, compounded and substandard Glucagon-like Peptide (GLP-1)-containing products being made available to the public via websites, social media platforms and other informal channels

Retatrutide won't reach pharmacies until 2028 at the earliest

Topical arnica gel or vitamin K creams may reduce bruise visibility, though scientific evidence for these is modest

These side effects are usually dose-dependent, meaning they can increase with higher doses of the medication